KORYTINA, G.F.,
AKHMADISHINA, L.Z.,
KOCHETOVA, O.V.,
VIKTOROVA, T.V.,
AZNABAEVA, Y.G.,
ZAGIDULLIN, SH.Z. (2019) and chemokine receptors (CCL11, CX3CR1, CCR5, CCL5, CXCL12, CCL2, and CCL17),
adhesion molecules (PECAM1
LIU, Z.,
ZHANG, R.,
CHEN, X.,
YAO, P.,
YAN, T.,
LIU, W.,
YAO, J.,
ZHAO, S.,
SOKHATSKII, A.,
GAREEV, I. (2019) , to act as therapeutic targets, and to identify potential small-
molecule compounds for treating ICH
TUGUZBAEVA, G.,
YUE, E.,
CHEN, X.,
HE, L.,
LI, X.,
JU, J.,
QIN, Y.,
PAVLOV, V.,
LU, Y.,
JIA, W.,
BAI, Y.,
NIU, Y.,
YANG, B (2019) integrin/FAK/Src signaling and disrupting E-cadherin-based
intercellular junctions possesses anti
systems for the processing of RNA
molecules. These systems have been and still remain the key sources